Reirradiation of recurrent and second primary head and neck malignancies: A comprehensive review

Cancer Treatment Reviews

Volumn 29, Issue 1, 2003, Pages 21-30

  Kao, Johnny ^a   Garofalo, Michael C ^a   Milano, Michael T ^a   Chmura, Steven J ^a   Citron, Jason R ^a   Haraf, Daniel J ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago   (United States)

Author keywords

Combined modality therapy; Recurrent head and neck cancer; Reirradiation

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; GEFITINIB; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; METHOTREXATE; MITOMYCIN; ONYX 015; PACLITAXEL; VASCULOTROPIN ANTIBODY;

CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; HEAD AND NECK CANCER; HUMAN; PREDICTION; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; SECOND CANCER; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0037302909     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(02)00096-8     Document Type: Review

References (59)

1. Forastiere A, Koch W, Trotti A, et al. Head and neck cancer. N Engl J Med 2001; 345: 1890-1900.
2. Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med 1993; 328: 184-194.
3. Million R, Cassisi N, Clark J. Cancer of the head and neck. In: Cancer: Principles and Practice of Oncology. Lippincott: Philadelphia, 1989; 488-590.
4. Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001; 19: 1961-1969.
5. Williams R. Recurrent head and neck cancer: the results of treatment. Br J Surg 1974; 61: 691-697.
6. Ridge J. Squamous cell cancer of the head and neck: surgical treatment of local and regional recurrence. Semin Oncol 1993; 20: 419-429.
7. Murphy B, Li Y, Cella D, et al. Phase III study comparing cisplatin and 5-fluorouracil versus cisplatin and paclitaxel in metastatic/recurrent head and neck cancer. Proc Am Soc Clin Oncol 2001; 20: 894a.
8. Jacobs C, Meyers F, Hendrickson C, et al. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer 1983; 52: 1563-1569.
9. Jacobs C, Lyman G, Velez-Garcia E, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992; 10: 257-263.
10. Bendahmane B, Bontemps P, Bourgeois H, et al. Final results of phase II study of patients with metastatic or recurrent squamous cell carcinoma of the head and neck treated with docetaxel and 5-fluorouracil. Proc Am Soc Clin Oncol 2000; 19: 1656a.
11. Forastierre AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin + fluorouracil and carboplatin + fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 1992; 10: 1245-1251.
12. Burtness BA, Li Y, Flood W, et al. Phase III trial comparing cisplatin and placebo to cisplatin and anti-epidermal growth factor antibody C225 in patients with metastatic/recurrent head and neck cancer. Proc Am Soc Clin Oncol 2002; 21: 901a.
13. The Liverpool Head and Neck Oncology Group. A phase III randomized trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous cell carcinoma of the head and neck. Br J Cancer 1990;61: 311-315.
14. Haraf DJ, Weichselbaum RR, Vokes EE. Reirradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 1996; 7: 913-918.
15. Haraf DJ, Chung K, Stenson M, et al. High dose re-irradiation with concomitant chemotherapy for local/regionally recurrent head and neck cancer (NHC): results in 48 patients. Proc Am Soc Clin Oncol 2000; 19: 413a.
16. Stevens Jr KR, Britsch A, Moss WT. High dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994; 29: 687-698.
17. Dawson LA, Myers LL, Bradford CR, et al. Conformal reirradiation of recurrent and new primary head and neck cancer. Int J Radiat Oncol Biol Phys 2001; 5O: 377-385.
18. Emami B, Bignardi M, Spector GJ, et al. Reirradiation of recurrent head and neck cancers. Laryngoscope 1987; 97: 85-88.
19. Pomp J, Levendag PC, van Putten WL. Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 1988; 11: 543-549.
20. Spencer SA, Wheeler, Peters GE, et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol 1999; 22: 1-5.
21. Gandia D, Wibault P, Guillot T, et al. Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head Neck 1993; 15: 8-15.
22. De Crevoisier R, Bourhis J, Domenge C, et al. Full dose reirradiation for unresectable head and neck carcinoma. Experience at the Gustave Roussy Institute in a series of 169 patients. J Clin Oncol 1998; 16: 3556-3562.
23. Weppelmann B, Wheeler RH, Peters GE, et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Int J Radiat Oncol Biol Phys 1992; 22: 1051-1056.
24. Benchalal M, Bachaud JM, Francois P, et al. Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study. Radiother Oncol 1995; 36: 203-210.
25. Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001; 51: 1299-1304.
26. Wang CC. Reirradiation of recurrent nasopharyngeal carcinoma - treatment techniques and results. Int J Radiat Oncol Biol Phys 1987; 13: 953-956.
27. Wang CC, McIntyre J. Reirradiation of laryngeal carcinoma - techniques and results. Int J Radiat Oncol Biol Phys 1993; 26: 783-785.
28. Teo PM, Kwan WH, Chan AT, et al. How successful is high dose (≥ 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 1998; 40: 897-913.
29. Jemal A, Thomas A, Murray T, et al. Cancer statistics. CA Cancer J Clin 2002; 52: 23-47.
30. Fremgen AM, Bland KI, McGinnis LS, et al. Clinical highlights from the national cancer database. CA Cancer J Clin 1999; 49: 145-158.
31. Al-Sarraf M, Pajak TF, Byhardt RW, et al. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced resectable head and neck cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys 1997; 37: 777-782.
32. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798-1804.
33. Forastiere AA, Berkey B, Maor M, et al. Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R 91-11. Prog Proc Am Soc Clin Oncol 2001; 20: 2a.
34. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7-16.
35. Hong W, Bromer R, Amato D, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 1985; 45: 1242-1245.
36. Kotwall C, Sako K, Razack MS, et al. Metastatic patterns in squamous; cell cancer of the head and neck. Am J Surg 1987; 154: 439-442.
37. Nishijima W, Takooda S, Tokita N, et al. Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol Head Neck Surg 1993; 119: 65-68.
38. Mabanta SR, Mendenhall WM, Stringer SP, et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 1999; 21: 591-594.
39. Rubin P. The law and order of radiation sensitivity, absolute vs. relative. In: Vaeth JM, Meyer JL (eds.), Radiation Tolerance of Normal Tissues Frontiers of Radiation Therapy and Oncology. Karger: Basel, Switzerland, 1989; 7-40.
40. Lee AW, Foo W, Law SC, et al. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys 1997; 38: 43-52.
41. Ang KK, Jiang GL, Feng Y, et al. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys 2001; 50: 1013-1020.
42. Nieder C, Milas L, Ang KK. Tissue tolerance to reirradiation. Semin Radiat Oncol 2000; 10: 200-209.
43. Weichselbaum RR, Beckett MA, Schwartz JL, et al. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys 1988; 15: 575-579.
44. Peiffert D, Pernot M, Malissard L. Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys 1994; 29: 681-686.
45. Langlois D, Hoffstetter S, Malissard L, et al. Salvage irradiation of oropharynx and mobile tongue with iridium 192 brachytherapy in Centre Alexis Vautrin. Int J Radiat Oncol Biol Phys 1988; 14: 849-853.
46. Hong WK, Bromer R. Chemotherapy in head and neck cancer. Current concepts. N Engl J Med 1983; 308: 75-79.
47. Richards GJ, Chambers RG. Hydroxyurea: a radiosensitizer in the treatment of neoplasms of the head and neck. Am J Roentgenol Radium Ther Nucl Med 1969; 105: 555-565.
48. Byfield JE, Calabro-Jones P, Klisak I, et al. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys 1982; 8: 1923-1933.
49. Frankfurt OS. Enhancement of the antitumor activity of 5-fluorouracil by drug combinations. Cancer Res 1973; 33: 1043-1047.
50. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990; 8: 911-934.
51. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three metaanalyses of updated individual data. MACH-NC Collaborative Group. Metaanalysis of chemotherapy on head and neck cancer. Lancet 2000; 355: 949-955.
52. De Crevoisier R, Domenge C, Wibault P, et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 2001; 91: 2071-2076.
53. Hwang JM, Fu KK, Phillips TL. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1998; 41: 1099-1111.
54. Chua DT, Sham JS, Kwong DL, et al. Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys 1998; 41: 379-386.
55. Levendag PC, Meeuwis CA, Visser AG. Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. Radiother Oncol 1992; 23: 6-15.
56. Langlois D, Exchwege F, Kramar A, et al. Reirradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute. Radiother Oncol 1985; 3: 27-33.
57. Stell PM. Time to recurrence of squamous cell carcinoma of the head and neck. Head Neck 1991; 13: 277-278.
58. Johnson LS, Milliken BD, Hadley SW, et al. Initial clinical experience with a video based patient positioning system. Int J Radiat Oncol Biol Phys 1999; 45: 205-213.
59. Mauceri HJ, Hanna NN, Beckett MA, et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 1998; 394: 287-291.